Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

RadNet Puts Focus on Efficiency as Imaging Reimbursement and Utilization Fall

RadNet will begin executing a cost savings program targeted at saving $30 million of annual operating costs in response to the reimbursement pressure and lower than anticipated utilization the company has experienced this year

Zotec Joins GE as a Top Supporter of ACR’s Radiology Leadership Institute

The billing and practice management services declined to confirm the exact size of its commitment. However, it is listed on the ACR’s website as a “Partner,” a distinction reserved for companies that contribute a half million or more

Pennsylvania Makes Informing Patients About Breast Density Mandatory

Governor Tom Corbett has signed the Breast Density Notification Act into law, making Pennsylvania the 13th state to require mammogram results sent to patients to include breast density information

National Breast Density Inform Bill Reintroduced

Supporters of the mandatory inclusion of breast density information in patient mammogram result notifications are making another run at getting a national law passed to require this of all imaging providers

Top 100 Private Practices List Reveals Advantage of Size

The value of scale became evident this year as the largest practices also reported the greatest revenue per FTE radiologist, and the revenue number stepped down with each descending practice-size category

Clinical Decision Support Mentioned in Both Versions of SGR Repeal Bill

On Wednesday, October 30, the House Ways and Means and Senate Finance Committees jointly released a draft version of policy to replace the sustainable growth rate formula (SGR), and language regarding the use of appropriateness criteria in ordering of advanced medical imaging was included

Merge Puts Positive Spin On Low Q3 Numbers

After a second quarter that was so bad, Merge’s own CEO, Justin Dearborn, called the results “unacceptable” and apologized to investors, the company’s third quarter results were less dramatic, but still not very inspiring to investors

GE Gets FDA Approval for Its Alzheimer’s Imaging Agent

The FDA has approved the GE Healthcare diagnostic imaging tracer flutemetamol F18 (Vizamyl) for use in evaluating adults for Alzheimer's disease and dementia